ArticleCancer research communications2026
Multiple Myeloma Screening Education: A Community-Based Health Literacy Intervention.
Article in Cancer research communications, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
13 authors.
Funding
Abstract
purposeTo address the lack of federal screening guidelines and a limited understanding of multiple myeloma among the public and some primary care providers, we created the first community-based multiple myeloma screening program and educational intervention. PATIENTS AND
methodsThe academic cancer center partnered with community organizations to distribute an original brochure about multiple myeloma, draw blood to check for monoclonal protein, and survey screening participants about multiple myeloma knowledge and screening experiences. Any Black individual aged 50 or older was eligible. To examine multiple myeloma knowledge retention, study team members surveyed participants after at least 1 week had passed and screening results had been provided. The educational intervention also included continuing medical education (CME) about the early detection of multiple myeloma for healthcare professionals. Analysis utilized descriptive statistics and the McNemar test to assess differences between the initial and follow-up surveys.
resultsFrom 2023 to 2024, across 22 screening events, 199 participants completed the screening. Among the 158 individuals who completed both surveys, correct responses increased on all items and increased significantly on items about multiple myeloma being a rare cancer of the blood (19%, P < 0.0001) and that individuals with monoclonal gammopathy of undetermined significance (MGUS) have an abnormal protein in the blood (12.1%, P = 0.002). Screening results identified 21 participants (11%) with MGUS. Forty-six healthcare providers engaged in three CME seminars.
conclusionsParticipants retained knowledge about multiple myeloma gained during the screening. Improved health literacy about cancer risk for multiple myeloma may improve early detection, communication, and decision-making about cancer care. SIGNIFICANCE: This study reveals that community members are receptive to multiple myeloma screening when healthcare professionals communicate with them about their risks and share knowledge about disease symptoms and incidence. Improved health literacy about cancer risk for multiple myeloma may improve early detection, communication, and decision-making about cancer care.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.